Indranil Basu

711 total citations
17 papers, 543 citations indexed

About

Indranil Basu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Indranil Basu has authored 17 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in Indranil Basu's work include Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Indranil Basu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Indranil Basu collaborates with scholars based in United States, India and Italy. Indranil Basu's co-authors include Chandan Guha, Vern L. Schramm, Thomas J. Belbin, E. Premkumar Reddy, Jonathan R. Hart, Peter K. Vogt, Stephen C. Cosenza, Kaushik Dutta, David J. Mulholland and Lisa Scandiuzzi and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Indranil Basu

15 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indranil Basu United States 9 344 158 70 62 50 17 543
Francisco J. Cimas Spain 13 330 1.0× 199 1.3× 78 1.1× 72 1.2× 81 1.6× 29 596
Joël S. Bloch Switzerland 11 307 0.9× 184 1.2× 104 1.5× 32 0.5× 36 0.7× 18 531
Toshihide Nishibata Japan 6 362 1.1× 161 1.0× 75 1.1× 14 0.2× 31 0.6× 8 492
Jin‐Qiu Chen United States 10 313 0.9× 282 1.8× 131 1.9× 23 0.4× 40 0.8× 17 602
Heike I. Krupka United States 11 332 1.0× 212 1.3× 41 0.6× 23 0.4× 30 0.6× 15 608
Chirayu Patel United States 8 331 1.0× 346 2.2× 63 0.9× 66 1.1× 56 1.1× 12 696
Elvin D. de Araujo Canada 13 305 0.9× 226 1.4× 68 1.0× 24 0.4× 21 0.4× 37 495
Valerie Sloane Jones China 7 200 0.6× 237 1.5× 208 3.0× 63 1.0× 37 0.7× 9 526
Chelsea McLean Netherlands 10 345 1.0× 140 0.9× 58 0.8× 45 0.7× 30 0.6× 21 552
Robert Hinderer United States 13 497 1.4× 116 0.7× 199 2.8× 55 0.9× 23 0.5× 14 754

Countries citing papers authored by Indranil Basu

Since Specialization
Citations

This map shows the geographic impact of Indranil Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indranil Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indranil Basu more than expected).

Fields of papers citing papers by Indranil Basu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indranil Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indranil Basu. The network helps show where Indranil Basu may publish in the future.

Co-authorship network of co-authors of Indranil Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Indranil Basu. A scholar is included among the top collaborators of Indranil Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indranil Basu. Indranil Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Dan, Vikas Mehta, Nicole Kawachi, et al.. (2023). CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma. Cancers. 15(7). 2005–2005. 10 indexed citations
2.
Prystowsky, Michael B., et al.. (2022). Abstract 203: The role of FOXM1 in senescence suppression and radiation resistance in oral cavity squamous cell carcinoma. Cancer Research. 82(12_Supplement). 203–203.
4.
Firestone, Ross, et al.. (2021). Transition state analogue of MTAP extends lifespan of APCMin/+ mice. Scientific Reports. 11(1). 8844–8844. 8 indexed citations
5.
Lázár‐Molnár, Eszter, Lisa Scandiuzzi, Indranil Basu, et al.. (2017). Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy. EBioMedicine. 17. 30–44. 48 indexed citations
6.
Divakar, Sai Krishna Athaluri, Rodrigo Vasquez‐Del Carpio, Kaushik Dutta, et al.. (2016). A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling. Cell. 165(3). 643–655. 205 indexed citations
7.
Quinn, Thomas J., Rafi Kabarriti, Lisa Scandiuzzi, et al.. (2016). Preclinical evaluation of radiation and systemic, RGD-targeted, adeno-associated virus phage-TNF gene therapy in a mouse model of spontaneously metastatic melanoma. Cancer Gene Therapy. 24(1). 13–19. 5 indexed citations
8.
Bandyopadhyay, Sanmay, Thomas J. Quinn, Lisa Scandiuzzi, et al.. (2016). Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. The Journal of Immunology. 196(4). 1964–1976. 61 indexed citations
9.
Mani, Kartik, Talicia Savage, Indranil Basu, et al.. (2016). Epigenetic Priming and High-Dose Radiation for Enhanced Immune Response in Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S86–S87.
10.
Brodin, N. Patrik, et al.. (2015). Semi-automatic cone beam CT segmentation ofin vivopre-clinical subcutaneous tumours provides an efficient non-invasive alternative for tumour volume measurements. British Journal of Radiology. 88(1050). 20140776–20140776. 6 indexed citations
11.
Skalina, Karin A., Huagang Zhang, Lisa Scandiuzzi, Indranil Basu, & Chandan Guha. (2015). Immunomodulation of prostate cancer cells after low energy focused ultrasound. Journal of Therapeutic Ultrasound. 3(S1). 4 indexed citations
12.
Basu, Indranil, Seema Gupta, Alan Alfieri, et al.. (2014). Rigosertib Is a More Effective Radiosensitizer Than Cisplatin in Concurrent Chemoradiation Treatment of Cervical Carcinoma, In Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 88(5). 1180–1187. 26 indexed citations
13.
Basu, Indranil, Joseph Locker, María B. Cassera, et al.. (2010). Growth and Metastases of Human Lung Cancer Are Inhibited in Mouse Xenografts by a Transition State Analogue of 5′-Methylthioadenosine Phosphorylase. Journal of Biological Chemistry. 286(6). 4902–4911. 57 indexed citations
14.
Schramm, Vern L., J. A. Gutierrez, Indranil Basu, et al.. (2008). Transition state analogues in quorum sensing and SAM recycling. Nucleic Acids Symposium Series. 52(1). 75–76. 26 indexed citations
15.
Basu, Indranil, et al.. (2007). A Transition State Analogue of 5′-Methylthioadenosine Phosphorylase Induces Apoptosis in Head and Neck Cancers. Journal of Biological Chemistry. 282(29). 21477–21486. 65 indexed citations
16.
Wang, Xintao, Haiyun Deng, Indranil Basu, & Liang Zhu. (2004). Induction of Androgen Receptor-Dependent Apoptosis in Prostate Cancer Cells by the Retinoblastoma Protein. Cancer Research. 64(4). 1377–1385. 19 indexed citations
17.
Basu, Aninda, Indranil Basu, Aruna Chakraborty, Soumitro Pal, & Utpala Chattopadhyay. (2003). Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen. International Journal of Cancer. 105(3). 377–383. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026